Decitabine and vasculitis Patient Reports February 10, 2010

Decitabine Side Effects Report #6068628-3
Decitabine side effect was reported by a Physician from PHILIPPINES on Jan 20, 2009. Female patient, 69 years of age, weighting 119.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: cellulitis , skin discolouration, vasculitis . Decitabine dosage: 20 MG/M2, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Decitabine Side Effects Report #6088961-9
Decitabine side effect was reported by a Physician from PHILIPPINES on Feb 05, 2009. Female patient, 69 years of age, weighting 119.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: cellulitis , skin discolouration, vasculitis . Decitabine dosage: 20 MG/M2, INTRAVENOUS. Patient was hospitalized and became disabled. Patient recovered.

Decitabine Side Effects Report #6108686-0
Decitabine side effect was reported by a Physician from PHILIPPINES on Feb 20, 2009. Female patient, 69 years of age, weighting 119.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Decitabine. After drug was administered, patient experienced the following side effects: vasculitis . Decitabine dosage: 20 MG/M2, INTRAVENOUS. Patient was hospitalized and became disabled. Patient recovered.

Decitabine Side Effects Report #5800550-7
Decitabine side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on June 20, 2008. Female patient, 67 years of age, weighting 143.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Decitabine. After drug was administered, patient experienced the following side effects: neutropenia, phlebitis, pyrexia, thrombosis, vasculitis . Decitabine dosage: 31.2 MG, IN 1 DAY, INTRAVENOUS; 31.2 MG, IN 1 DAY, INTRAVENOUS; 31.8 MG, IN 1 DAY, INTRAVENOUS. During the same period patient was treated with SENNA, METOCLOPRAMIDE, DIPHENHYDRAMINE, BETAMETHASONE, GLYCYRRHIZA, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.


Decitabine Side Effects Report #5869314-2
Decitabine side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Aug 13, 2008. Female patient, 67 years of age, weighting 143.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Decitabine. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, disease progression, neutropenia, phlebitis, pyrexia, thrombosis, vasculitis . Decitabine dosage: 31.2 MG, 1 IN 1 DAY, INTRAVENOUS; 31.8 MG, 1 IN 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.

Decitabine Side Effects Report #5877391-8
Decitabine side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Aug 27, 2008. Female patient, 67 years of age, weighting 143.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Decitabine. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, malignant neoplasm progression, neutropenia, phlebitis, vasculitis . Decitabine dosage: 31.2 MG; 31.2 MG; 31.8 MG; 31.8 MG, 1 IN 1 DAY, INTRAVENOUS. During the same period patient was treated with SENNA, METOCLOPRAMIDE, DIPHENHYDRAMINE, BETAMETHASONE, GLYCYRRHIZA. Patient was hospitalized. Patient recovered.

Decitabine Side Effects Report #5887054-0
Decitabine side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Aug 13, 2008. Female patient, 67 years of age, weighting 143.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Decitabine. After drug was administered, patient experienced the following side effects: neutropenia, phlebitis, thrombosis, vasculitis . Decitabine dosage: 31.2 MG, 1 IN 1 DAY; INTRAVENOUS, 31.8 MG, 1 IN 1 DAY; INTRAVENOUS. During the same period patient was treated with SENNA. Patient was hospitalized. Patient recovered.